Judith Carser

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Gerhardt Attard, Laura Murphy, Noel W. Clarke et al. · The Lancet Oncology · 2023 · 102 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E. Brown, Kara‐Louise Royle, Walter M. Gregory et al. · The Lancet Oncology · 2023 · 81 citations · Full text

Medicine, Oncology, Pharmacology +11

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer

Judith Carser, Jennifer E. Quinn, Caroline O. Michie et al. · Gynecologic Oncology · 2011 · 64 citations

Medicine, Gynecology, Oncology +12

Could a low-cost audio-visual link be useful in rheumatology?

Lorraine Graham, S Mcgimpsey, Stephen Wright et al. · Journal of Telemedicine and Telecare · 2000 · 30 citations

Medicine, Clinical Sciences, Clinical Medicine +10

Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer

Judith Carser, Yvonne Summers · Journal of Thoracic Oncology · 2006 · 25 citations · Full text

Medicine, Oncology, Pharmacology +9